SEC Form 4 · accession 0001127602-19-009282
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin Hourican
Officer — EVP & President, CVS Pharmacy
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | F | 4,489 | $57.83 | D | 311 | D | |
| Common StockF2 | Feb 28, 2019 | A | 9,467 | $57.83 | A | 9,778 | D | |
| Common Stock (restricted) | holding | — | — | — | 9,355 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.
- F2Consists of stock awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan.